Enasidenib

• Description :

  An orally available, selective, potent inhibitor of mutant IDH2 with IC50s of 100-400 nM for IDH2R140Q homodimer.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  473.375

• Molecular Formula :

  C19H17F6N7O

• Notes :

  Research use only, not for human use.

• Receptor :

  IDH2

• CAS Number :

  1446502-11-9